10x Genomics, Inc.
TXG
$11.22
-$0.48-4.10%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 393.40M | 398.16M | 380.09M | 371.81M | 388.70M |
Total Receivables | 87.86M | 83.53M | 91.18M | 91.31M | 114.83M |
Inventory | 83.11M | 94.05M | 88.27M | 83.19M | 73.71M |
Prepaid Expenses | 20.02M | 18.16M | 19.61M | 20.79M | 18.79M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 584.39M | 593.89M | 579.16M | 567.09M | 596.02M |
|
|||||
Total Current Assets | 584.39M | 593.89M | 579.16M | 567.09M | 596.02M |
Net Property, Plant & Equipment | 309.94M | 318.34M | 324.16M | 332.34M | 344.93M |
Long-term Investments | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M |
Goodwill | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M |
Total Other Intangibles | 15.67M | 16.15M | 16.66M | 16.13M | 16.62M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 4.13M | 4.90M | 5.19M | 2.84M | 3.06M |
Total Assets | 918.64M | 937.79M | 929.67M | 922.91M | 965.14M |
|
|||||
Total Accounts Payable | 12.91M | 26.21M | 21.25M | 20.22M | 15.74M |
Total Accrued Expenses | 52.07M | 48.87M | 40.52M | 40.34M | 45.98M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 9.29M | 9.42M | 10.82M | 11.13M | 11.52M |
Total Finance Division Other Current Liabilities | 43.37M | 36.74M | 38.43M | 37.05M | 53.93M |
Total Other Current Liabilities | 43.37M | 36.74M | 38.43M | 37.05M | 53.93M |
Total Current Liabilities | 117.63M | 121.24M | 111.02M | 108.73M | 127.16M |
|
|||||
Total Current Liabilities | 117.63M | 121.24M | 111.02M | 108.73M | 127.16M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 73.33M | 76.46M | 78.66M | 81.05M | 83.85M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 17.54M | 17.29M | 15.93M | 14.30M | 13.09M |
Total Liabilities | 208.50M | 214.99M | 205.61M | 204.08M | 224.10M |
|
|||||
Common Stock & APIC | 2.18B | 2.14B | 2.11B | 2.06B | 2.03B |
Retained Earnings | -1.47B | -1.42B | -1.38B | -1.34B | -1.28B |
Treasury Stock & Other | -493.00K | 32.00K | -430.00K | -456.00K | -429.00K |
Total Common Equity | 710.13M | 722.80M | 724.06M | 718.83M | 741.04M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 710.13M | 722.80M | 724.06M | 718.83M | 741.04M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 710.13M | 722.80M | 724.06M | 718.83M | 741.04M |
|